Prothena (NASDAQ:PRTA) Given New $110.00 Price Target at Piper Sandler
Prothena (NASDAQ:PRTA – Free Report) had its target price upped by Piper Sandler from $94.00 to $110.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. PRTA has been the topic of a number of other reports. Royal Bank of Canada reduced their […]
Prothena (NASDAQ:PRTA – Free Report) had its target price upped by Piper Sandler from $94.00 to $110.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. PRTA has been the topic of a number of other reports. Royal Bank of Canada reduced their […]
